Australian Technical Advisory Group on Immunisation (ATAGI) Annual Statement on Immunisation 2023

The ATAGI 2023 Annual Statement on Immunisation is the third publication in this series. It covers key successes, trends and challenges in the use of vaccines and control of vaccine-preventable diseases in 2023. It also signals ATAGI’s priority actions for addressing key issues for 2023.

Downloads

Australian Technical Advisory Group on Immunisation (ATAGI) Annual Statement on Immunisation 2023

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Date last updated:
Publication type:
Statement
Audience:
General public
Language:
English
Description:

In 2022, governments across Australia eased COVID-19 pandemic-related community and border control measures. As social interactions increased, the rate of some common vaccine-preventable diseases, especially influenza, also grew. There were also significant outbreaks of 2 newly emerged diseases, Japanese encephalitis and mpox (formerly known as monkeypox). The responses to these new Communicable Disease Incidents of National Significance (CDINS) included establishing vaccination programs against these diseases.

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.